|  Help  |  About  |  Contact Us

Comment :

Type  MGI:General Description  with chronic administration (for 7 days) of 1-desamno-8-D-arginine vasopressin (DDAVP) increases urine osmolality in mutants but not in controls; elevation does not persist past 3 days of DDAVP administration